Episode Details
Back to EpisodesS7E10: Fresh from Munich: Plozasiran and the SHASTA-3 & SHASTA-4 Trial Results
Description
Hot off the European Society of Cardiology Congress in Munich, this Lipid Insights episode takes a closer look at a significant announcement in triglyceride science and its implications for clinical practice. Host Peter H. Jones, MD, MNLA sits down with Christie M. Ballantyne, MD, MNLA to discuss the 12-month pivotal trial results from SHASTA-3 and SHASTA-4 — evaluating plozasiran in patients with severe hypertriglyceridemia. If you missed Munich, this is your catch-up.
Watch the video version on YouTube HERE.
The National Lipid Association Lipid Insights podcast series brings you engaging discussions on the most relevant, timely, and groundbreaking topics in lipidology. Hosted by Dr. Alan Brown and Dr. Peter Jones, this series explores the latest research, emerging treatments, and key developments in the field. Whether it’s expert analysis on hot topics, deep dives into new clinical data, or conversations about the evolving landscape of lipid management, each episode delivers insightful and thought-provoking content. With their expertise and dynamic hosting style, Dr. Brown and Dr. Jones make each discussion both informative and entertaining—ensuring listeners walk away with valuable knowledge to enhance their understanding and clinical practice. Tune in to Lipid Insights and stay at the forefront of lipidology!
For all things lipidology, visit the NLA's website.